Monopar Therapeutics

Edit info

Founded: 2014

Location: Wilmette, IL

Employee range: 11 - 50

Clinical stage: Clin2

Therapy area: Chemoradiation-induced oral mucositis

Drug types: ORL, ONC, INF

Lead product: Validive

Funding: $9M IPO Dec 2019; $9M Nov 2019

monopartx.com

linkedin.com

job board

Drug notes:

Camsirubicin Clin1b soft tissue sarcoma; MNPR-101 RIT RD/Clin0 solid tumors, RD/Clin0 COVID-19; MNPR-101 RD/Clin0 solid tumors; MNPR-202 RD/Clin0 solid tumors

About:

Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing cancer therapeutics that either extend lives or improve patient quality of life. They aim to use their scientific and clinical expertise to reduce risk and accelerate clinical development of drug candidates. Monopar was founded in 2014 with current facilities located in San Francisco, CA and Chicago, IL.

Jobs:

Main

Contact: recruit@workinbiotech.com